MOGN Mgi Pharma (MM)

MGI PHARMA, INC. (Nasdaq:MOGN) will broadcast its fourth quarter and year end 2005 financial results in a conference call with investors live over the Internet on Wednesday, February 8, 2006 at 5:00 p.m. Eastern Time. Lonnie Moulder, President and CEO of MGI PHARMA, and members of the Company's executive management team, will review financial results, answer questions from analysts and investors, and provide commentary on MGI PHARMA's business outlook. All interested parties are welcome to listen to this audio webcast. MGI PHARMA will issue its fourth quarter and year end 2005 financial results news release after the market closes on Wednesday, February 8, 2006. -0- *T What: MGI PHARMA's Fourth Quarter and Year End Results Conference Call When: Wednesday, February 8, 2006 at 5:00 p.m. Eastern Time How: Live over the Internet - simply log on to www.mgipharma.com. In addition to the live webcast, the presentation will be archived on the Company's Web site for one week. *T About MGI PHARMA MGI PHARMA, INC. is an oncology- and acute care-focused biopharmaceutical company that acquires, researches, develops and commercializes proprietary products that address the unmet needs of patients. MGI PHARMA markets Aloxi(R) (palonosetron hydrochloride) injection and Gliadel(R) Wafer (polifeprosan 20 with carmustine implant) in the United States. The Company directly markets its products in the U.S. and collaborates with partners to reach international markets. For more information about MGI PHARMA, please visit www.mgipharma.com.